Get the Stockscreener App
0.735
2.47%
-0.0186
Biofrontera Inc stock is traded at $0.735, with a volume of 243.38K.
It is down -2.47% in the last 24 hours and down -26.26% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$0.7536
Open:
$0.78
24h Volume:
243.38K
Relative Volume:
1.14
Market Cap:
$8.74M
Revenue:
$39.19M
Net Income/Loss:
$-16.59M
P/E Ratio:
-0.3368
EPS:
-2.182
Net Cash Flow:
$-9.39M
1W Performance:
-10.11%
1M Performance:
-26.26%
6M Performance:
+13.76%
1Y Performance:
-3.16%
1-Day Range:
$0.7117
$0.7999
1-Week Range:
$0.7117
$0.8999
52-Week Range:
$0.536
$1.87
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.75 | 8.78M | 39.19M | -16.59M | -9.39M | -2.182 |
|
ZTS
Zoetis Inc
|
120.80 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.29 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.8675 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.18 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
473.07 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Biofrontera Inc Stock (BFRI) Latest News
How reliable is Biofrontera Inc. (AI10) stock dividend growthEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Why Biofrontera Inc. Equity Warrant is moving todayJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Biofrontera Inc. (AI10) stock could outperform next yearJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
News impact scoring models applied to Biofrontera Inc.Weekly Trade Summary & Weekly Hot Stock Watchlists - newser.com
Will Biofrontera Inc. (AI10) stock benefit from commodity supercycleGDP Growth & Safe Entry Trade Reports - newser.com
What high frequency data says about Biofrontera Inc. Equity Warrant2025 Retail Activity & Verified Entry Point Signals - newser.com
Published on: 2025-11-19 16:39:27 - newser.com
Tools to assess Biofrontera Inc. Equity Warrant’s risk profileJuly 2025 Market Mood & AI Powered Market Entry Strategies - newser.com
Will Biofrontera Inc. (AI10) stock sustain bullish trend into 20252025 Volatility Report & Community Shared Stock Ideas - newser.com
Will Biofrontera Inc. stock deliver long term returnsEarnings Risk Report & AI Forecast Swing Trade Picks - newser.com
Why Biofrontera Inc. stock is trending among retail tradersMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Will Biofrontera Inc. (AI10) stock return to pre crash levelsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
How forex fluctuations impact Biofrontera Inc. (AI10) stockDollar Strength & Free Reliable Trade Execution Plans - newser.com
Can Biofrontera Inc. (AI10) stock survive global slowdownAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Biofrontera Inc. stock momentum explainedJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Why Biofrontera Inc. stock could be next big winnerQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Will Biofrontera Inc. Equity Warrant stock outperform Dow Jones indexWeekly Market Summary & Fast Momentum Stock Entry Tips - newser.com
Why Biofrontera Inc. (AI10) stock is favored by hedge fundsTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.48%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):